Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Frequency of Tuberculosis in Psoriasis Patients
A completed clinical trial investigates how frequently tuberculosis occurs in patients with psoriasis. The study concerns psoriasis vulgaris…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis [EARLY_Phase 1]
An early-phase (Phase 1) trial comparing topical 1% methotrexate gel with clobetasol propionate in patients with psoriasis has completed. Th…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Elocon vs Fluticasone in Localized Psoriasis (P03197) [Phase 4]
A Phase 4 trial comparing mometasone furoate (Elocon) with fluticasone propionate in localized psoriasis has completed, reporting comparativ…
-
FDA approval · 2024-08-05FDA Approved: ACITRETIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the Original Application for Acitretin from Alembic Pharmaceuticals Inc., a generic version of this retinoid. Acitretin is used…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients
Completed clinical trial evaluating serum M2BP and musculoskeletal ultrasound as predictors of arthritis in patients with psoriasis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety Study of Mirikizumab (LY3074828) [Phase 1]
Phase 1 safety study of mirikizumab (LY3074828) in psoriasis completed; results posted in 2024. The study assessed safety and tolerability i…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Blue Light in the Treatment of Inflammatory Skin Diseases [NA]
A completed clinical trial evaluating blue light therapy for inflammatory skin diseases. The study, conducted by the Medical University of L…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Effects of Tildrakizumab on Epigenetic Age [Phase 4]
Phase 4 clinical trial assessing the effect of tildrakizumab on epigenetic age in patients with psoriasis; the study status is completed.
-
FDA approval · 2024-07-15FDA Approved: TAZAROTENE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Original Application for Tazarotene, establishing a generic topical retinoid. The product …
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Biofeedback for Psoriasis [NA]
A completed clinical trial evaluating biofeedback for psoriasis has finished its study.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis [Phase 4]
Phase 4 study assessing the efficacy and safety of VTAMA (tapinarof) 1% cream for intertriginous plaque psoriasis has completed with results…
-
EMA approval · 2024-07-04EMA Authorised: Sotyktu (deucravacitinib) — Bristol-Myers Squibb Pharma EEIG
The European Medicines Agency authorised Sotyktu (deucravacitinib) by Bristol-Myers Squibb Pharma EEIG for psoriasis in the European Union.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
The PICASSO trial is a prospective psoriasis follow-up cohort study that is currently recruiting at Universitaire Ziekenhuizen KU Leuven.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Cream Containing Sericin and Turmeric in Psoriasis Patients [NA]
A clinical trial update for a cream containing sericin and turmeric being studied for psoriasis; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis [NA]
A University of Crete clinical trial evaluating metabolic biomarkers in Hashimoto's thyroiditis and psoriasis; the study is currently active…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Correction of Psoriatic T Cell Signatures by Deucravacitinib [Phase 4]
Phase 4 trial investigating whether deucravacitinib can correct psoriatic T cell signatures in psoriasis, currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis
This clinical trial investigates the analytical validation of a wrist-worn device for measuring nocturnal scratching in individuals with ato…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis [NA]
This clinical trial update describes using the SpiderMass system for in vivo skin analysis across five chronic inflammatory dermatoses and n…
-
FDA approval · 2024-06-03FDA Approved: METHOTREXATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for methotrexate, authorizing the generic version of the drug.
-
FDA approval · 2024-05-21FDA Approved: CYCLOSPORINE — Original Application (Devatis Inc.)
FDA approved Devatis Inc.'s cyclosporine as a generic drug under an original ANDA (ANDA209811).
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Low-Dose Enoxaparin in Psoriasis [NA]
A clinical trial is evaluating low-dose enoxaparin for psoriasis. The study is currently not yet recruiting, with Zagazig University listed …
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: The Diagnostic Ultrasound Enthesitis Tool (DUET) Study
The DUET study, sponsored by Women's College Hospital, has completed its clinical evaluation of the Diagnostic Ultrasound Enthesitis Tool (D…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Observational Study of Apremilast in Patients With Psoriasis in The Netherlands
An observational study of Apremilast in patients with psoriasis in the Netherlands has completed.
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients
This clinical trial update reports on expression levels of IL-17, Bcl-3, and IκBζ in psoriasis patients to study inflammatory pathway activi…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Value Based Healthcare in Psoriasis [NA]
A clinical trial update about a study evaluating value-based healthcare approaches in psoriasis. It is currently recruiting at University Ho…